- PR Newswire•11 months ago
NEW YORK, Feb. 26, 2016 /PRNewswire/ -- WeissLaw LLP, a national class action, shareholder rights law firm with offices in New York and Los Angeles, announces an investigation of ERBA Diagnostics, Inc. ("ERB" or the "Company"). On November 20, 2015, ERB announced that the financial statements for the years ended December 31, 2013 and 2014, and the interim periods ended March 31 and June 30, 2015 should not be relied upon as accurate. The Company reported that an investigation by its Audit Committee concluded that the financial statements for the past ten quarters contain material weaknesses resulting in an expected increase in net loss in the range of $3.0- $4.0 million. Following that announcement, ERB shares dropped approximately 20% from $1.74 to $1.44. On December 1, 2015, the Company suffered another crushing blow when it announced that it was facing a possible suspension and delisting from the New York Stock Exchange.
- Business Wire•last yearDEADLINE TODAY: The Law Offices of Vincent Wong Notify Investors of Class Action Involving ERBA Diagnostics, Inc. and a Lead Plaintiff Deadline of February 1, 2016
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Southern District of Florida on behalf of investors who purchased ERBA Diagnostics, Inc.
- Accesswire•last yearDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against ERBA Diagnostics, Inc. and Lead Plaintiff Deadline: February 1, 2016
NEW YORK, NY / ACCESSWIRE / February 1, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a securities class action has been filed on behalf of those who purchased shares of ERBA Diagnostics, ...
Requested symbol wasn't found
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|